Lineage Cell Therapeutics stock price
리니지 셀 테라퓨틱스NYSEAMERICAN:LCTX · NYSE Amex · Healthcare · sector #17$0.9379+1.13%
2026-10-06 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Lineage Cell Therapeutics last closed at $0.9379 (+1.13%) on 2026-10-06. Listed on NYSE Amex. Trailing 12 months PER is -7.6×. Its overall grade ranks 448 of 740 stocks in Healthcare.
About this company
Lineage Cell Therapeutics last closed at $0.9379 (+1.13%) on 2026-10-06. Listed on NYSE Amex.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 448/740
Valuation grade B+
Related stocks
- AstellasCustomer
세포치료제 협력·개발 파트너로 연결된 대형 제약사
- Bristol Myers SquibbCustomer
세포치료·재생의학 분야의 잠재적 파트너/라이선스 고객
- Allogene TherapeuticsCompetitor
동종 CAR-T·세포치료제 개발 경쟁사
About Lineage Cell Therapeutics
- What technical signals does Lineage Cell Therapeutics (LCTX) have?
- Lineage Cell Therapeutics current technical signals: no active technical signal.
- Is Lineage Cell Therapeutics a cup-and-handle pattern?
- No. Lineage Cell Therapeutics has no valid Cup signal right now.
- What published figures are available for Lineage Cell Therapeutics?
- Market cap: $216.02M. Trailing 12 months PER: -7.6×. Latest quarter PBR: 4.10×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-07 dataset
Turn what you saw on this name into a strategy
Ask Q about Lineage Cell Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy